Cargando…

Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma

BACKGROUND: Emerging studies revealed that cancer stem cells (CSCs) possessed peculiar metabolic properties, which however remained largely unknown in hepatocellular carcinoma (HCC). Genetic silencing of liver-abundant miR-192-5p was a key feature for multiple groups of CSC-positive HCCs. We thus ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yuanzhuo, Ji, Fubo, Liu, Niya, Zhao, Yongzhi, Wei, Xiyang, Hu, Shiyuan, Jia, Wei, Wang, Xin Wei, Budhu, Anuradha, Ji, Juling, Zhao, Bin, Roessler, Stephanie, Zheng, Xin, Ji, Junfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708108/
https://www.ncbi.nlm.nih.gov/pubmed/33256802
http://dx.doi.org/10.1186/s13046-020-01785-7
_version_ 1783617496392138752
author Gu, Yuanzhuo
Ji, Fubo
Liu, Niya
Zhao, Yongzhi
Wei, Xiyang
Hu, Shiyuan
Jia, Wei
Wang, Xin Wei
Budhu, Anuradha
Ji, Juling
Zhao, Bin
Roessler, Stephanie
Zheng, Xin
Ji, Junfang
author_facet Gu, Yuanzhuo
Ji, Fubo
Liu, Niya
Zhao, Yongzhi
Wei, Xiyang
Hu, Shiyuan
Jia, Wei
Wang, Xin Wei
Budhu, Anuradha
Ji, Juling
Zhao, Bin
Roessler, Stephanie
Zheng, Xin
Ji, Junfang
author_sort Gu, Yuanzhuo
collection PubMed
description BACKGROUND: Emerging studies revealed that cancer stem cells (CSCs) possessed peculiar metabolic properties, which however remained largely unknown in hepatocellular carcinoma (HCC). Genetic silencing of liver-abundant miR-192-5p was a key feature for multiple groups of CSC-positive HCCs. We thus aimed to investigate essential metabolic features of hepatic CSCs via using HCCs with miR-192-5p silencing as a model. METHODS: Datasets from two independent HCC cohorts were used. Data integration analyses of miR-192-5p with metabolome and mRNA transcriptome data in HCC Cohort 1 were performed to investigate miR-192-5p related metabolic features, which was further validated in Cohort 2. Cellular and molecular assays were performed to examine whether and how miR-192-5p regulated the identified metabolic features. Co-culture systems consisting of HCC cells and LX2 (human hepatic stellate cell line) or THP1 (human monocyte cell line) were established to explore effects of the identified metabolic properties on stemness features of HCC cells via interacting with co-cultured non-tumor cells. RESULTS: High levels of glycolysis-related metabolites and genes were present in HCCs with low miR-192-5p and CSC-positive HCCs in two independent HCC cohorts. miR-192-5p knockout cells displayed CSC features and miR-192-5p loss led to an enhanced glycolytic phenotype via upregulating three bona fide targets, GLUT1 and PFKFB3 (two glycolytic enzymes) and c-Myc (regulating glycolytic genes’ expression). Meanwhile, c-Myc suppressed miR-192-5p transcription, ensuring a low-miR-192-5p/high-c-Myc loop to maintain hyperglycolysis. Moreover, over-produced lactic acid from hyperglycolytic HCC cells stimulated the ERK phosphorylation of co-cultured LX2 and THP1 non-tumor cells partially via NDRG3 and MCT1, which in turn promoted cell malignancy and stemness of HCC cells. Consistently, HCC patients with low level of miR-192-5p in their tumor tissues and high level of NDRG3 or MCT1 in their non-tumor tissues had the shortest overall survival. CONCLUSIONS: In CSC-positive HCCs, miR-192-5p loss enhanced glycolysis and over produced lactate might further increase HCC malignant features via interacting with environmental non-tumor cells. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-020-01785-7.
format Online
Article
Text
id pubmed-7708108
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77081082020-12-02 Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma Gu, Yuanzhuo Ji, Fubo Liu, Niya Zhao, Yongzhi Wei, Xiyang Hu, Shiyuan Jia, Wei Wang, Xin Wei Budhu, Anuradha Ji, Juling Zhao, Bin Roessler, Stephanie Zheng, Xin Ji, Junfang J Exp Clin Cancer Res Research BACKGROUND: Emerging studies revealed that cancer stem cells (CSCs) possessed peculiar metabolic properties, which however remained largely unknown in hepatocellular carcinoma (HCC). Genetic silencing of liver-abundant miR-192-5p was a key feature for multiple groups of CSC-positive HCCs. We thus aimed to investigate essential metabolic features of hepatic CSCs via using HCCs with miR-192-5p silencing as a model. METHODS: Datasets from two independent HCC cohorts were used. Data integration analyses of miR-192-5p with metabolome and mRNA transcriptome data in HCC Cohort 1 were performed to investigate miR-192-5p related metabolic features, which was further validated in Cohort 2. Cellular and molecular assays were performed to examine whether and how miR-192-5p regulated the identified metabolic features. Co-culture systems consisting of HCC cells and LX2 (human hepatic stellate cell line) or THP1 (human monocyte cell line) were established to explore effects of the identified metabolic properties on stemness features of HCC cells via interacting with co-cultured non-tumor cells. RESULTS: High levels of glycolysis-related metabolites and genes were present in HCCs with low miR-192-5p and CSC-positive HCCs in two independent HCC cohorts. miR-192-5p knockout cells displayed CSC features and miR-192-5p loss led to an enhanced glycolytic phenotype via upregulating three bona fide targets, GLUT1 and PFKFB3 (two glycolytic enzymes) and c-Myc (regulating glycolytic genes’ expression). Meanwhile, c-Myc suppressed miR-192-5p transcription, ensuring a low-miR-192-5p/high-c-Myc loop to maintain hyperglycolysis. Moreover, over-produced lactic acid from hyperglycolytic HCC cells stimulated the ERK phosphorylation of co-cultured LX2 and THP1 non-tumor cells partially via NDRG3 and MCT1, which in turn promoted cell malignancy and stemness of HCC cells. Consistently, HCC patients with low level of miR-192-5p in their tumor tissues and high level of NDRG3 or MCT1 in their non-tumor tissues had the shortest overall survival. CONCLUSIONS: In CSC-positive HCCs, miR-192-5p loss enhanced glycolysis and over produced lactate might further increase HCC malignant features via interacting with environmental non-tumor cells. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-020-01785-7. BioMed Central 2020-11-30 /pmc/articles/PMC7708108/ /pubmed/33256802 http://dx.doi.org/10.1186/s13046-020-01785-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gu, Yuanzhuo
Ji, Fubo
Liu, Niya
Zhao, Yongzhi
Wei, Xiyang
Hu, Shiyuan
Jia, Wei
Wang, Xin Wei
Budhu, Anuradha
Ji, Juling
Zhao, Bin
Roessler, Stephanie
Zheng, Xin
Ji, Junfang
Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma
title Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma
title_full Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma
title_fullStr Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma
title_full_unstemmed Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma
title_short Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma
title_sort loss of mir-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708108/
https://www.ncbi.nlm.nih.gov/pubmed/33256802
http://dx.doi.org/10.1186/s13046-020-01785-7
work_keys_str_mv AT guyuanzhuo lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma
AT jifubo lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma
AT liuniya lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma
AT zhaoyongzhi lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma
AT weixiyang lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma
AT hushiyuan lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma
AT jiawei lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma
AT wangxinwei lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma
AT budhuanuradha lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma
AT jijuling lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma
AT zhaobin lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma
AT roesslerstephanie lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma
AT zhengxin lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma
AT jijunfang lossofmir1925pinitiatesahyperglycolysisandstemnesspositivefeedbackinhepatocellularcarcinoma